Results

Total Results: 1,613 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

201. Cer-250-Cannabis-Apps-A-E-Surveillance-Report-2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
     January 01, 2022 - Reporting on adverse events was sparse. … , nausea, sedation) and withdrawals from studies due to adverse events. … , nausea, sedation) and study withdrawal due to adverse events. … events, and withdrawals due to adverse events for each included study. … scale; WAE = withdrawal due to due adverse events.

202. Cannabis-Annual-Update2-Table-E5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-table-e5.xlsx
     March 13, 2023 - Events Other Reported Outcomes Funding Source Risk of Bias 21087411 Bestard, 2011 Prospective cohort … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse events … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverse … events: 4.65% (10/215) vs.

203. Cannabis-2022-Update-Surv-Rep-1-App-F-5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
     January 01, 2022 - Events Other Reported Outcomes Funding Source Risk of Bias 21087411 Bestard, 2011 Prospective cohort … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse events … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverse … events: 4.65% (10/215) vs.

204. Cannabis-2022-Surv-Rep-3-Table-F5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
     January 01, 2022 - Events Other Reported Outcomes Funding Source Risk of Bias 21087411 Bestard, 2011 Prospective cohort … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse events … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverse … events: 4.65% (10/215) vs.

205. Nonopioid Pharmacologic Treatments for Chronic Pain | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/nonopioid-chronic-pain/protocol
     March 01, 2019 - adverse events (including falls, fractures, motor vehicle accidents), and specific adverse events, according … events, and serious adverse events. … Specific adverse events for each drug class, such as gastrointestinal events, cardiovascular events, … events, serious adverse events, overdose (intentional and unintentional), misuse, and dependence. … Key specific adverse events, according to drug class, such as gastrointestinal and cardiovascular events

206. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
     February 01, 2019 - Harms and Adverse Events a. … adverse events, according to drug class? … events, and serious adverse events. … Specific adverse events for each drug class, such as gastrointestinal events, cardiovascular events, … events, serious adverse events, overdose (intentional and unintentional), misuse, and dependence

207. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/inguinal-hernia_research-protocol.pdf
     August 15, 2011 - no mesh Outcomes Patient-oriented effectiveness outcomes and adverse events (see list of outcomes … Adverse events include any unintended effects such as chronic pain, infection, small bowel perforation … The following will always be considered objective outcomes: adverse events, hospital stay, office … This item will only be used for the following outcomes: hernia recurrence, adverse events, QOL, FCT … MCSDs for different adverse events If meta-analysis is deemed appropriate and possible for a given

208. Transparency of Reporting Requirements: Effectiveness of Treatments Options for the Prevention of Complications and Treatment of Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
     September 01, 2016 - events by organ system. 2. … • Adverse event and deaths. … ClinicalTrials.gov began to mandate reporting of adverse events in September 2009 as serious adverse … events and non-serious adverse events. … We will compare the total adverse events reported in ClinicalTrials.gov compared with the total reported

209. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
     December 29, 2015 - When lesinurad was combined with xanthine oxidase inhibitors, commonly reported adverse events were … However, the experts warned that lesinurad uptake could be limited by concern about adverse events, … adverse events, than patients given placebo. … Occurrence of adverse events, including serious events, was similar in patients given baricitinib or … Adverse events/nonfatal serious adverse events rates were 78.1%/8.6% and 82.4%/12.9% in patients who

210. Appendixes A-I: (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-appendixes.pdf
     April 01, 2022 - events and withdrawals due to adverse events for each included study. … ; VAS = visual analog scale; WAE = withdrawal due to due adverse events. … Events and Withdrawals Due to Adverse Events Bestard, 2011 Moderate Prospective cohort Neuropathic … Events and Withdrawals Due to Adverse Events Lee, 2021b Moderate Matched cohort NR A: Chronic … scale; WAE = withdrawal due to due adverse events.

211. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - When lesinurad was combined with xanthine oxidase inhibitors, commonly reported adverse events were … However, they warned, lesinurad uptake could be limited by adverse events, such as kidney complications … back pain, nasopharyngitis, and upper respiratory tract infection.6 The most common adverse events … The experts warned that lesinurad uptake could be limited by adverse events such as kidney complications … events, which could require additional adverse event monitoring while patients are taking lesinurad

212. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
     April 01, 2022 - adverse events according to drug class? … Harms and Adverse Events a. … adverse events according to drug class? … events, and serious adverse events. … Specific adverse events for each drug class, such as gastrointestinal events, cardiovascular events,

213. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
     March 01, 2022 - Reporting on adverse events was sparse. … , nausea, sedation) and withdrawals from studies due to adverse events. … , nausea, sedation) and study withdrawal due to adverse events. … events, and withdrawals due to adverse events for each included study. … scale; WAE = withdrawal due to due adverse events.

214. Acute Treatment for Episodic Migraine: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-2.pdf
     June 01, 2022 - No serious adverse events were observed. … There were no treatment- related adverse events. … and withdrawals due to adverse events compared with placebo. … No serious adverse events were observed. … No treatment related adverse events were reported.

215. Dietary-Supplements Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
     April 01, 2012 - to adverse events)? … events, withdrawal due to adverse events, renal dysfunction, hepatotoxicity, QT interval, and bleeding … No withdrawals due to adverse events or other adverse events were observed.59 Garlic Four small short-term … events, bleeding, renal dysfunction, hepatotoxicity, and serious adverse events). … events,42,73 renal dysfunction,42,73 serious adverse events,42 diarrhea,73 vomiting,73 nausea,73 adverse

216. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
     October 01, 2010 - of the various adverse events were not always comparable." … Limitations of evaluation of adverse events have been added to Discussion section. … Discussion Adverse effects: “There is a moderate level of evidence to show that adverse events associated … These long-term adverse events need to be explored in future studies. … types of adverse events were different between groups, as would be expected.

217. Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Artery Stenting: Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/coronary-artery-stenting/research
     February 26, 2013 - FFR confers a lower risk of the composite endpoint of death or myocardial infarction (MI) or of major adverse … cardiac events; and (c) FFR leads to fewer stents implanted and reduces the cost of the procedure. … cardiac events or its individual components. … intermediate coronary lesion confers a lower risk of composite endpoint of death or MI, or of major adverse … cardiac events; leads to fewer stents being implanted; and reduces procedural costs.

218. Tympanostomy Tubes in Children with Otitis Media | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/tympanostomy-tubes/research-2017
     May 05, 2017 - Benefits of TT placement must be weighed against a variety of adverse events. … with chronic otitis media with effusion and recurrent acute otitis media, summarize the frequency of adverse … The benefits of TT placement must be weighed against a variety of adverse events.

219. Topic Coming Back CER 28 DMARDs in Children with JIA NSD _SJ Clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
     March 27, 2014 - In children with JIA, does the rate and type of adverse eventsf differ between the various DMARDs or … How do the efficacy, effectiveness, safety, and adverse effects of treatment with DMARDs differ among … with DMARDs, we focused primarily on serious infections and the development of cancer when assessing adverse … events. … Other adverse events considered included mortality, hepatitis, bone marrow suppression, nausea or vomiting

220. Weight-Loss-Surgery Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_executive.pdf
     June 01, 2013 - had no adverse events data. … Thus, strength of evidence for long-term adverse events is rated insufficient. … Data reported on adverse events also have several limitations. … event category; thus, the rate estimate for most adverse events is imprecise. … As such, the rates of adverse events may be biased and lower than actual.